Pharmacokinetics and protein binding of salicylate metabolites in rats
Morris, M.E.
Drug Metabolism and Disposition the Biological Fate of Chemicals 18(5): 809-811
1990
ISSN/ISBN: 0090-9556 PMID: 1981740 Document Number: 353214
Document emailed within 1 workday
Related Documents
Matsushima, H.; Kamimura, H.; Soeishi, Y.; Watanabe, T.; Higuchi, S.; Tsunoo, M. 1998: Pharmacokinetics and plasma protein binding of tamsulosin hydrochloride in rats, dogs, and humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(3): 240-245Daniel, W.; Syrek, M.; Janczar, L.; Boksa, J. 1995: The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine Polish Journal of Pharmacology 47(2): 127-136
Yu, H.Y.; Shen, Y.Z.; Sugiyama, Y.; Hanano, M. 1990: Drug interaction. Effects of salicylate on pharmacokinetics of valproic acid in rats Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(1): 121-126
Brion, N.; Contrepois, A.; Carbon, C. 1983: From serum pharmacokinetics to extravascular pharmacokinetics of antibiotics. Importance of protein binding Presse Medicale 12(5): 293-296
Mattila, M.J.; Nieminen, E.; Vapaatalo, H.I.; Brander, E. 1972: Modification by sodium salicylate and paraaminosalyicylic acid of the protein binding and antimycobacterial effect of isoniazid in vitro Arzneimittel-Forschung 22(10): 1769-1771
Liu, J.H.; Malone, R.S.; Stallings, H.; Smith, P.C. 1996: Influence of renal failure in rats on the disposition of salicyl acyl glucuronide and covalent binding of salicylate to plasma proteins Journal of Pharmacology and Experimental Therapeutics 278(1): 277-283
DeVane, C.L.; Simpkins, J.W. 1985: Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose Drug Metabolism and Disposition: the Biological Fate of Chemicals 13(4): 438-442
Belpaire, F. 1987: Effect of inflammation on blood protein binding, pharmacokinetics and pharmacodynamics of drugs Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 49(1): 83-97
Belpaire, F.M.; De Rick, A.; De Smet, F.; Bourda, A.; Rosseel, M.T.; Bogaert, M.G. 1989: Influence of lidocaine on plasma protein binding and pharmacokinetics of verapamil in dogs Progress in Clinical and Biological Research 300: 437-440
Stepanenko, O.'g.V.; Povarova, O.I.; Fonin, A.V.; Stepanenko, O.V. 2010: Stability of sugar-binding proteins: D-galactose/D-glucose-binding protein from Escherichia coli and trehalose/maltose-binding protein from Thermococcus litoralis Tsitologiia 52(11): 950-954
Ehrnebo, M. 1974: Pharmacokinetics of pentobarbital in humans with special reference to blood cell and plasma protein binding Acta Pharmaceutica Suecica 11(6): 655-656
Erlichman, C.; Strong, J.M.; Chabner, B.A. 1980: Application of a simple competitive protein-binding assay technique to the pharmacokinetics of N-(phosphonacetyl)-L-aspartate in humans Cancer Research 40(6): 1902-1906
Gascon, M.P.; Porchet, H.C.; Le Cotonnec, J.Y.; Ythier, A.; Wallach, D.; Piguet, P.F.; Grau, G.E. 1992: Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in mice Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(4): 592-595
Belpaire, F.M.; Vanderheeren, F.A.; Bogaert, M.G. 1975: Binding of thioridazine and some of its metabolites to human serum protein and human albumin Arzneimittel-Forschung 25(12): 1969-1971
Imawari, M.; Akanuma, Y.; Itakura, H.; Muto, Y.; Kosaka, K.; Goodman, D.S. 1979: The effects of diseases of the liver on serum 25-hydroxyvitamin D and on the serum binding protein for vitamin D and its metabolites Journal of Laboratory and Clinical Medicine 93(1): 171-180
Done, A.K. 1974: Salicylate, pharmacokinetics, and the pediatrician Pediatrics 54(6): 670-672
Chen, C.L.; Sangiah, S.; Roder, J.D.; Chen, H.; Berlin, K.D.; Garrison, G.L.; Scherlag, B.J.; Lazzara, R. 1995: Pharmacokinetics and plasma protein binding of the new potent class IIi antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorate Arzneimittel-Forschung 45(6): 670-675
Dean, M.; Penglis, S.; Stock, B. 1989: The pharmacokinetics of salicylate in the pregnant Wistar rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 17(1): 87-90
Yamada, Y.; Endo, M.; Kohno, M.; Otsuka, M.; Takaiti, O. 1992: Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys Arzneimittel-Forschung 42(4): 499-506
Trnavský, K.; Zachar, M. 1976: A contribution to the pharmacokinetics of some of the latest salicylate drugs Casopis Lekaru Ceskych 115(18): 552-555